首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1449573

醫藥精細化學品市場：按類型、按產品、按應用、按地區

Pharmaceutical Fine Chemicals Market, By Type, By Product, By Application, By Geography

出版日期: 2024年02月02日 | 出版商:

Coherent Market Insights | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

醫藥精細化學品市場呈現顯著成長，預計從2024年的 1,362 億美元增至2031年的 2,335 億美元，預計2024年至2031年期間年複合成長率將達到 8%。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	1362億美元
實際資料	2019-2023	預測期	2024-2031
預測期間2023/2024 至2030/2031年年複合成長率：	8.00%	2030/2031價值預測	2335億美元

圖1.2024年醫藥精細化學品市場區域佔有率（%）

近年來，醫藥精細化學品市場經歷了顯著成長。醫藥精細化學品是指用於藥物製劑的活性藥物成分及原料藥。慢性病增加、老年人口增加以及生物製藥公司對藥物開發的研發投入增加等因素推動對醫藥精細化學品的需求。此外，自訂合成和製造服務越來越受歡迎，因為它們可以幫助藥廠最佳化成本並致力於其他活動。原料藥製造商和製劑公司之間的各種長期供應協議也支撐著醫藥精細化學品市場。然而，嚴格的法律規範和與藥物開發過程相關的高成本給推動市場成長帶來了挑戰。總體而言，全球醫藥精細化學品市場預計在未來幾年將呈現利潤豐厚的機會。

市場動態：

醫藥精細化學品市場是由世界老年人口增加（更容易患慢性病），醫療保健支出增加以及文明病患病率增加等因素所推動的。據聯合國表示，到2050年，世界上六分之一的人將超過65歲。此外，製藥公司用於藥物開發和採用契約製造支出的增加推動市場成長。然而，他們面臨藥品核准嚴格的法規環境以及藥品製造相關的高成本等挑戰。同時，在原料藥生產過程中擴大採用自訂合成和製造，為相關人員提供了巨大的機會。此外，將原料藥製造外包到低成本和熟練勞動力的新興市場為市場相關人員開闢新的途徑。

本研究的主要特點

本報告對全球醫藥精細化學品市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球醫藥精細化學品市場的主要企業。
本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球醫藥精細化學品市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

市場動態
- 促進因素
對生物相似藥的需求不斷成長
政府醫療保健支出增加
- 抑制因素
由於合規性導致生產成本增加
容量限制輸出限制
- 機會
精細化工製造外包
生技藥品和生物相似藥市場的成長
影響分析
主要亮點
監管場景
產品發布/核准
PEST分析
波特的分析
併購場景

第4章醫藥精細化學品市場-冠狀病毒（COVID-19）大流行的影響

新型冠狀病毒感染疾病（COVID-19）的流行病學
供需面分析
經濟影響

第5章 2019-2031年醫藥精細化學品市場，依類型

專利
非專利

第6章醫藥精細化學品市場，依產品，2019-2031

基本構成要素
中間體
有效成分

第7章 2019-2031年醫藥精細化學品市場，依應用

心血管
神經系統
腫瘤學
感染疾病
代謝系統
糖尿病
呼吸系統
胃
黏膜骨架
其他

第8章 2019-2031年醫藥精細化學品市場，依地區

北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
中東、非洲
GCC
以色列
其他中東地區
拉丁美洲
墨西哥
阿根廷
巴西

第9章競爭格局

公司簡介
- Denisco
- Albemarle Corporation
- Kenko Corporation
- GRACE
- CHEMADA
- JMP Statistical Discovery LLC.
- Pfizer Inc.
- GSK plc

第10章

調查方法
關於出版商

簡介目錄

Product Code: CMI6602

The pharmaceutical fine chemicals market is projected to exhibit substantial growth, increasing from US$ 136.2 Bn in 2024 to an estimated US$ 233.5 Bn by 2031 this growth is anticipated to be driven by a notable CAGR of 8% during the period of 2024-2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 136.2 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.00%	2030/2031 Value Projection:	US$ 233.5 Bn

Figure 1. Pharmaceutical Fine Chemicals Market Share (%), by Region, 2024

Pharmaceutical Fine Chemicals Market - IMG1

The pharmaceutical fine chemicals market has been witnessing significant growth over the past few years. Pharmaceutical fine chemicals refer to active pharmaceutical ingredients or bulk drug substances which are used in pharmaceutical formulations. Factors, such as rising prevalence of chronic diseases, increasing elderly population, and growing research and development investments in drug development by biopharmaceutical companies, are fueling the demand for pharmaceutical fine chemicals. Furthermore, custom synthesis and manufacturing services are gaining traction as they help drug manufacturers optimize costs and focus on other core activities. Various agreements between Active Pharmaceutical Ingredients makers and drug formulation businesses for long term supply are also propelling the pharmaceutical fine chemicals market. However, stringent regulatory framework and high costs associated with drug development processes pose challenges to boost the market growth. Overall, the global pharmaceutical fine chemicals market is anticipated to showcase lucrative opportunities in the coming years.

Market Dynamics:

The pharmaceutical fine chemicals market is driven by factors such as growing geriatric population globally prone to chronic diseases, rising healthcare expenditure, and increasing incidence of lifestyle diseases. As per the United Nations, by 2050, one in six people in the world will be over age 65. Furthermore, increasing R&D spending on drug development by pharmaceutical companies and the adoption of contract manufacturing are fueling the market growth. However, the market faces challenges from stringent regulatory environment for drug approval and high costs associated with drug manufacturing. On the other hand, the growing adoption of custom synthesis and manufacturing in the API production process presents significant opportunities for stakeholders. Additionally, outsourcing of API manufacturing to emerging markets with low-cost skilled labor is opening new avenues for market players.

Key features of the study:

This report provides an in-depth analysis of the global pharmaceutical fine chemicals market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharmaceutical fine chemicals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Denisco, Albemarle Corporation, Kenko Corporation, GRACE, CHEMADA, JMP Statistical Discovery LLC., Pfizer Inc., GSK plc.,
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pharmaceutical fine chemicals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation:

Pharmaceutical Fine Chemicals Market, By Type
- Proprietary
- Non Proprietary
Pharmaceutical Fine Chemicals Market, By Product
- Basic Building Blocks
- Advanced Intermediates
- Active Ingredients
Pharmaceutical Fine Chemicals Market, By Application
- Cardiovascular
- Neurological
- Oncological
- Infectious Diseases
- Metabolic System
- Diabetes
- Respiratory
- Gastrointestinal
- Mucoskeletal
- Others
Pharmaceutical Fine Chemicals Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Top companies in the pharmaceutical fine chemicals market
- Denisco
- Albemarle Corporation
- Kenko Corporation
- GRACE
- CHEMADA
- JMP Statistical Discovery LLC.
- Pfizer Inc.
- GSK plc.

Market Dynamics
- Drivers
Rising Demand for Biosimilars
Increasing Government Healthcare Spending
- Restraints
Regulatory Compliance Increasing Production Costs
Capacity Limitations Restricting Output
- Opportunities
Outsourcing of Fine Chemicals Production
Growth in Biologics and Biosimilars Market
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Pharmaceutical Fine Chemicals Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Pharmaceutical Fine Chemicals Market, By Type, 2019 - 2031 (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Proprietary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Non Proprietary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)

6. Pharmaceutical Fine Chemicals Market, By Product, 2019 - 2031 (US$ Bn)

Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Basic Building Blocks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Advanced Intermediates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Active Ingredients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)

7. Pharmaceutical Fine Chemicals Market, By Application, 2019 - 2031 (US$ Bn)

Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Neurological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Oncological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Metabolic System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Mucoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2031, (US$ Bn)

8. Pharmaceutical Fine Chemicals Market, By Region, 2019 - 2031 (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 - 2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031,(US$ Bn)
GCC
Israel
Rest of Middle East
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031,(US$ Bn)
Mexico
Argentina
Brazil